Avinger Inc
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to prov… Read more
Avinger Inc (AVGR) - Net Assets
Latest net assets as of September 2024: $3.88 Million USD
Based on the latest financial reports, Avinger Inc (AVGR) has net assets worth $3.88 Million USD as of September 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($13.60 Million) and total liabilities ($9.73 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $3.88 Million |
| % of Total Assets | 28.49% |
| Annual Growth Rate | N/A |
| 5-Year Change | -189.95% |
| 10-Year Change | N/A |
| Growth Volatility | 323.19 |
Avinger Inc - Net Assets Trend (2012–2023)
This chart illustrates how Avinger Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Avinger Inc (2012–2023)
The table below shows the annual net assets of Avinger Inc from 2012 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | $-6.20 Million | -249.59% |
| 2022-12-31 | $4.15 Million | -57.36% |
| 2021-12-31 | $9.72 Million | -25.64% |
| 2020-12-31 | $13.08 Million | +89.64% |
| 2019-12-31 | $6.89 Million | -27.11% |
| 2018-12-31 | $9.46 Million | +126.51% |
| 2017-12-31 | $-35.69 Million | -941.55% |
| 2016-12-31 | $4.24 Million | -72.79% |
| 2015-12-31 | $15.59 Million | +110.84% |
| 2014-12-31 | $-143.87 Million | -27.56% |
| 2013-12-31 | $-112.78 Million | -53.14% |
| 2012-12-31 | $-73.64 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Avinger Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 34602800000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $1.00K | % |
| Other Components | $414.49 Million | % |
| Total Equity | $-6.20 Million | 100.00% |
Avinger Inc Competitors by Market Cap
The table below lists competitors of Avinger Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
WORLD ACCEPTANCE
BE:WOA
|
$1.26 Million |
|
JEMTEC Inc
V:JTC
|
$1.26 Million |
|
OCEAN SUN AS NK -01
F:OW7
|
$1.26 Million |
|
Amir Marketing and Investments in Agriculture Ltd
TA:AMRK
|
$1.26 Million |
|
Hexagon Energy Materials Limited
F:F93
|
$1.26 Million |
|
IDH DEVELOPMENT S.A.
F:7E2
|
$1.26 Million |
|
Sierra Grande Minerals Inc
OTCQB:SIERF
|
$1.26 Million |
|
Shemen Industries Ltd
TA:SMNIN
|
$1.26 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Avinger Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 4,146,000 to -6,202,000, a change of -10,348,000 (-249.6%).
- Net loss of 18,320,000 reduced equity.
- New share issuances of 5,112,000 increased equity.
- Other factors increased equity by 2,860,000.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-18.32 Million | -295.39% |
| Share Issuances | $5.11 Million | +82.43% |
| Other Changes | $2.86 Million | +46.11% |
| Total Change | $- | -249.59% |
Book Value vs Market Value Analysis
This analysis compares Avinger Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-12-31 | $-898097.56 | $0.47 | x |
| 2013-12-31 | $-1375390.24 | $0.47 | x |
| 2014-12-31 | $-1754487.80 | $0.47 | x |
| 2015-12-31 | $148466.67 | $0.47 | x |
| 2016-12-31 | $21419.19 | $0.47 | x |
| 2017-12-31 | $-128844.77 | $0.47 | x |
| 2018-12-31 | $2655.81 | $0.47 | x |
| 2019-12-31 | $285.76 | $0.47 | x |
| 2020-12-31 | $79.68 | $0.47 | x |
| 2021-12-31 | $30.89 | $0.47 | x |
| 2022-12-31 | $9.95 | $0.47 | x |
| 2023-12-31 | $-7.89 | $0.47 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Avinger Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -239.41%
- • Asset Turnover: 0.56x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-249.16%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | 0.00% | -395.61% | 0.28x | 0.00x | $-26.50 Million |
| 2013 | 0.00% | -307.78% | 0.52x | 0.00x | $-28.62 Million |
| 2014 | 0.00% | -285.06% | 0.45x | 0.00x | $-17.58 Million |
| 2015 | -303.70% | -441.93% | 0.20x | 3.47x | $-48.90 Million |
| 2016 | -1323.46% | -292.12% | 0.36x | 12.63x | $-56.55 Million |
| 2017 | 0.00% | -490.56% | 0.66x | 0.00x | $-45.16 Million |
| 2018 | -291.31% | -348.17% | 0.33x | 2.51x | $-28.50 Million |
| 2019 | -286.47% | -216.32% | 0.38x | 3.46x | $-20.44 Million |
| 2020 | -151.60% | -226.26% | 0.26x | 2.54x | $-21.13 Million |
| 2021 | -213.00% | -204.44% | 0.34x | 3.03x | $-21.68 Million |
| 2022 | -420.33% | -210.65% | 0.34x | 5.84x | $-17.84 Million |
| 2023 | 0.00% | -239.41% | 0.56x | 0.00x | $-17.70 Million |
Industry Comparison
This section compares Avinger Inc's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,985,661,714
- Average return on equity (ROE) among peers: -36.09%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Avinger Inc (AVGR) | $3.88 Million | 0.00% | 2.51x | $1.26 Million |
| ANGELALIGN TECHNOLOGY INC (AGLFF) | $480.24 Million | 2.52% | 0.41x | $405.57 Million |
| Akoya Biosciences Inc (AKYA) | $-30.16 Million | 0.00% | 0.00x | $16.24 Million |
| Alcon AG (ALC) | $19.68 Billion | 1.70% | 0.48x | $37.82 Billion |
| Align Technology Inc (ALGN) | $3.85 Billion | 10.94% | 0.61x | $11.75 Billion |
| AngioDynamics Inc (ANGO) | $355.71 Million | 3.06% | 0.15x | $354.40 Million |
| Ansell Limited (ANSLF) | $386.33 Million | -0.45% | 0.87x | $2.58 Billion |
| AptarGroup Inc (ATR) | $2.07 Billion | 11.57% | 1.03x | $8.27 Billion |
| AtriCure Inc (ATRC) | $72.60 Million | -15.79% | 0.54x | $1.42 Billion |
| Anteris Technologies Global Corp. Common Stock (AVR) | $9.03 Million | -338.35% | 0.77x | $156.14 Million |